3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Recruiting
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Colorectal Neoplasms
14
Rectal Neoplasms
5
Neoplasm Metastasis
5
Cholangiocarcinoma
4
Stomach Neoplasms
3
Colonic Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Carcinoma, Hepatocellular
3
Biliary Tract Neoplasms
3
Adenocarcinoma Of Esophagus
3
Ovarian Neoplasms
2
Neoplasms
2
Gastrointestinal Neoplasms
2
Gallbladder Neoplasms
2
Esophageal Neoplasms
2
Recurrence
1
Pathologic Complete Response
1
Lung Neoplasms
1
Gastroesophageal Adenocarcinoma
1
Endometrial Neoplasms
1
Disease Progression
1
Central Nervous System Neoplasms
1
Carcinoma, Basal Cell
1
Breast Neoplasms
1
Bile Duct Neoplasms
1
Adenocarcinoma of the Lower Rectum
1
Adenocarcinoma
1
Interventions
pembrolizumab
38
Bevacizumab
23
Cyclophosphamide
22
Standard of Care
18
Blood Specimen Collection
17
Carboplatin
16
Paclitaxel
15
Nivolumab
14
Gemcitabine
14
Pemetrexed
13
Exercise
13
Cisplatin
12
atezolizumab
11
Radiotherapy
11
Fluorouracil
11
Doxorubicin
11
Surveys and Questionnaires
9
Rituximab
9
Oxaliplatin
9
Magnetic Resonance Spectroscopy
9
Leucovorin
9
Cetuximab
9
Biopsy
9
130-nm albumin-bound paclitaxel
9
durvalumab
8
abemaciclib
8
Docetaxel
8
olaparib
7
Temozolomide
7
Prednisone
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Neoplasms
×
Folfox protocol
×
90 days
×
Clear all
NCT06846346
2026-04-28
GRACIE
UNICANCER
Phase 2
Recruiting
88 enrolled
NCT06475352
2026-04-23
FUDOSE
UNICANCER
Phase 2
Recruiting
400 enrolled